Actiste® Mini receives market approval in the Kingdom of Saudi Arabia
Brighter AB (publ) is proud to announce that the diabetes management device Actiste® Mini has received market approval from the Saudi Food and Drug Authority (SFDA).
Actiste® Mini is a smart and user-friendly blood glucose meter with global out-of-the-box internet connectivity through eSIM, aiming to support successful diabetes management and monitoring.
The new device, based on the original Actiste® hardware technology platform, will be a key component in a new service currently being developed by Brighter.
In November 2020, Brighter announced that the company's first product, Actiste®, developed for insulin treated diabetes, received market approval in Saudi Arabia.
With Actiste® Mini, and the original Actiste® service designed for insulin treated diabetes, Brighter can address the whole diabetes community.
For further information, please contact:
Investor Relations
IR@brighter.se
Henrik Norström, CEO
+46 733 40 30 45
henrik.norstrom@brighter.se
Certified Adviser
Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 10, adviser@eminova.se, www.eminova.se.
About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.
This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 12:35 CET on December 18, 2020.